Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
3,396,258
-
Share change
-
-338
-
Total reported value
-
$46,661,907
-
Price per share
-
$13.74
-
Number of holders
-
42
-
Value change
-
-$4,880
-
Number of sells
-
1
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q4 2013
As of 31 Dec 2013,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,396,258 shares.
The largest 10 holders included
Pentwater Capital Management LP, Polar Capital LLP, WASATCH ADVISORS INC, BlackRock Fund Advisors, Iguana Healthcare Management, LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., FMR LLC, Alyeska Investment Group, L.P., and NORTHERN TRUST CORP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.